摘要Objective: To establish a rat model of Alzheimer's disease with depression, and to explore the common serum indicators that can be used to assess the occurrence of depression in Alzheimer's disease patients by routine blood testing. Methods: 120 healthy male SD rats were randomly divided into healthy group, control group, dementia group and dementia with depression group, with 30 rats in each group. The rats in the three groups were tested for the basic biological markers by means of routine serum monitoring. Results: 30 rats in each healthy group and control group, 28 rats in dementia group and 27 rats in dementia with depression group completed the experiment. There were statistical differences in the levels of each biomarker in the four groups of rats (P<0.05); there was no statistical difference in the levels of each biomarker between the healthy group and the control group (P>0.05); The levels of serum IL-1β, IL-6, TNF-α, CRP, and Hcy in the dementia group were higher than those in the healthy group and the control group, and the 5-HT levels were lower than those in the healthy group and the control group (P<0.05); The levels of IL-1β, IL-6, TNF-α, CRP, and Hcy in the depression group were higher than those in the other three groups, and the levels of 5-HT were lower than those in the other three groups (P>0.05). Conclusion: The occurrence of depressive symptoms in Alzheimer's rats can be predicted to some extent by routine serum IL-1β, IL-6, TNF-α, CRP, Hcy and 5-HT levels, and it is inferred that the above indicators can be used as important biological markers to assess the occurrence of depression in Alzheimer's patients.
Abstract：Objective: To establish a rat model of Alzheimer's disease with depression, and to explore the common serum indicators that can be used to assess the occurrence of depression in Alzheimer's disease patients by routine blood testing. Methods: 120 healthy male SD rats were randomly divided into healthy group, control group, dementia group and dementia with depression group, with 30 rats in each group. The rats in the three groups were tested for the basic biological markers by means of routine serum monitoring. Results: 30 rats in each healthy group and control group, 28 rats in dementia group and 27 rats in dementia with depression group completed the experiment. There were statistical differences in the levels of each biomarker in the four groups of rats (P<0.05); there was no statistical difference in the levels of each biomarker between the healthy group and the control group (P>0.05); The levels of serum IL-1β, IL-6, TNF-α, CRP, and Hcy in the dementia group were higher than those in the healthy group and the control group, and the 5-HT levels were lower than those in the healthy group and the control group (P<0.05); The levels of IL-1β, IL-6, TNF-α, CRP, and Hcy in the depression group were higher than those in the other three groups, and the levels of 5-HT were lower than those in the other three groups (P>0.05). Conclusion: The occurrence of depressive symptoms in Alzheimer's rats can be predicted to some extent by routine serum IL-1β, IL-6, TNF-α, CRP, Hcy and 5-HT levels, and it is inferred that the above indicators can be used as important biological markers to assess the occurrence of depression in Alzheimer's patients.
SHI Lei, LIN Duo-duo, WANG Wei-bing, WU Hai-long. Study on Basic Biomarkers of Alzheimer's Disease with Depression[J]. 中国生物医学工程学报(英文版）, 2023, 32(1): 19-24.
SHI Lei, LIN Duo-duo, WANG Wei-bing, WU Hai-long. Study on Basic Biomarkers of Alzheimer's Disease with Depression. Chinese Journal of Biomedical Engineering, 2023, 32(1): 19-24.
[1] Miguel-Yanes D, Jose M, Jimenez-Garcia, et al.Hospital admissions in people with Alzheimer's disease or senile dementia according to type 2 diabetes status: An observational 10-year study[J]. Am J Alzheimers Dis Other Demen, 2018,33(1):12-19. [2] Weidner WS, Barbarino P.The state of the art of dementia research: New frontiers[J]. Alzheimer's and Dementia, 2019, 15(7):1473. [3] Alzheimer′s Disease International (ADI). World Alzheimer Report2018:the state of the art of dementia research: new frontiers[R]. London:Alzheimer′s Disease International (ADI),2018. [4] Hu AM,Xue ZM,Liu ZN,et al.Unipolar depression and bipolar depression manifest different brain abnormalities:A voxel-based morphometry study[J]. Journal of Psychiatry and Brain Science,2016,1(2):4. [5] Starkstein SE, Jorge R, Mizrahi R, et al.The construct of minor and major depression in Alzheimer's disease[J]. Am J Psychiatry, 2005,162(1):2086-2093. [6] Ownby RL, Crocco E, Acevedo A, et al.Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis[J]. Arch Gen Psychiartry, 2006,63(5):530-538. [7] King E, O'Brien JT, Donaghy P, et al. Peripheral inflammation in prodromal alzheimer's and lewy body dementias[J]. J Neurol Neurosurg Psychiato,2018,89(4):339-345. [8] Aruna A, Ilango K, Singh PK, et al.Age dependent levels of plasma homocysteine and cognitive performance[J]. Behav Brain Res,2015,283(11):139-144.
